Immunosuppression is an independent prognostic factor associated with aggressive tumor behavior in cutaneous melanoma

This publication has 13 references indexed in Scilit:

• Survival After Cutaneous Melanoma in Kidney Transplant Recipients: A Population-Based Matched Cohort Study
  American Journal of Transplantation, 2014
• Melanoma Survival Disadvantage in Young, Non-Hispanic White Males Compared With Females
  JAMA Dermatology, 2013
• Population-Based 20-Year Survival Among People Diagnosed With Thin Melanomas in Queensland, Australia
  Journal of Clinical Oncology, 2012
• Melanoma survival in the United States, 1992 to 2005
  Journal of the American Academy of Dermatology, 2011
• Prognostic Significance of Mitotic Rate in Localized Primary Cutaneous Melanoma: An Analysis of Patients in the Multi-Institutional American Joint Committee on Cancer Melanoma Staging Database
  Journal of Clinical Oncology, 2011
• De Novo Cancers Arising in Organ Transplant Recipients are Associated With Adverse Outcomes Compared With the General Population
  Transplantation, 2009
• Melanoma in Organ Transplant Recipients: Clinicopathological Features and Outcome in 100 Cases
  American Journal of Transplantation, 2008
• Survival Differences Between Patients With Scalp or Neck Melanoma and Those With Melanoma of Other Sites in the Surveillance, Epidemiology, and End Results (SEER) Program
  Archives of Dermatology, 2008
• Age and gender are significant independent predictors of survival in primary cutaneous melanoma
  Cancer, 2008
• Factors Predicting the Risk of In-Transit Recurrence After Sentinel Lymphonodectomy in Patients With Cutaneous Malignant Melanoma
  Annals of Surgical Oncology, 2006